Phio Pharmaceuticals Corp. (PHIO) › Capital ExpendituresPhio Pharmaceuticals Corp. (PHIO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $15.0K2013: $78.0K2014: $95.0K2015: $57.0K2016: $4.0K2017: $203.0K2018: $5.0K2019: $72.0K2020: $19.0K2021: $51.0K2022: $121.0K2023: $5.0K2024: $1.0K2025: $12.0K$12.0K2012Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$12.0K+1100.0%2024$1.0K-80.0%2023$5.0K-95.9%2022$121.0K+137.3%2021$51.0K+168.4%2020$19.0K-73.6%2019$72.0K+1340.0%2018$5.0K-97.5%2017$203.0K+4975.0%2016$4.0K-93.0%2015$57.0K-40.0%2014$95.0K+21.8%2013$78.0K+420.0%2012$15.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share